Efficacy and safety of oral granisetron and dexamethasone for crizotinib-induced nausea and vomiting in patient with non-small cell lung cancer (NSCLC)
Not Applicable
Recruiting
- Conditions
- on-small cel lung cancer
- Registration Number
- JPRN-UMIN000017997
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with symptomatic CNS metastases. 2) Documented history of severe autoimmune disease required systemic steroids. 3) Patients with digestive disease associated with symptom of nausea, vomiting and appetite loss
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete response rate
- Secondary Outcome Measures
Name Time Method